Compounds > mandelalide a

Page last updated: 2024-08-03 21:16:47

mandelalide a

Description

mandelalide A: from Ascidians; structure in first source [MeSH]

Cross-References

ID Source	ID
PubMed CID	60200818
MeSH ID	M000595470

Synonyms (1)

Synonym
mandelalide a

Research

Studies (11)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	10 (90.91)	24.3611
2020's	1 (9.09)	2.80

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	11 (100.00%)	84.16%

Substance	Studies	Classes	Roles	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
molybdenum	1	chromium group element atom	micronutrient	2014	2014	10.0	high	0	0	0	0	1	0
silver	1	copper group element atom; elemental silver	Escherichia coli metabolite	2016	2016	8.0	high	0	0	0	0	1	0
erlotinib hydrochloride	1	hydrochloride; terminal acetylenic compound	antineoplastic agent; protein kinase inhibitor	2022	2022	2.0	high	0	0	0	0	0	1

Condition	Indicated	Studies	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
Astrocytoma, Grade IV	0	1	2022	2022	2.0	medium	0	0	0	0	0	1
Benign Neoplasms	0	1	2016	2016	8.0	medium	0	0	0	0	1	0
Cancer of Lung	0	2	2016	2022	5.0	medium	0	0	0	0	1	1
Carcinoma, Non-Small Cell Lung	0	1	2022	2022	2.0	medium	0	0	0	0	0	1
Carcinoma, Non-Small-Cell Lung	0	1	2022	2022	2.0	medium	0	0	0	0	0	1
Glioblastoma	0	1	2022	2022	2.0	medium	0	0	0	0	0	1
Lung Neoplasms	0	2	2016	2022	5.0	medium	0	0	0	0	1	1
Neoplasms	0	1	2016	2016	8.0	medium	0	0	0	0	1	0

Safety/Toxicity (1)

Article	Year
Discovery of Mandelalide E and Determinants of Cytotoxicity for the Mandelalide Series. Organic letters, , Mar-18, Volume: 18, Issue:6	2016